AI assistant
DEVRO PLC — Regulatory Filings 2022
Nov 25, 2022
4717_bfr_2022-11-25_09b607f8-1911-4ba2-8b6a-f4b000cce4df.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6232H
Devro PLC
25 November 2022
25 November 2022
Devro plc
Trading Update
Performing strongly
Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 30 June to 31 October 2022 ("period").
Current trading
The Group traded strongly in the period with reported revenue growth of 16% (10% at constant currency) compared to the prior year period. Constant currency revenue growth was driven by higher pricing, successful recovery of inflation, as well as good volume increases led by our mature markets. Volume growth continues to reflect the successful execution of our strategy. Operating margins in the period were up on the prior year and well ahead of those achieved in the first half.
Mature markets were strong with continued growth in North America and Continental Europe. Emerging market growth was particularly strong in the Middle East and Africa and South East Asia however, as expected, the termination of sales to Russia impacted overall progress for this region in the period.
Outlook
Current trading and the full year outlook are slightly ahead of the Board's expectations, underpinned by a robust performance and foreign exchange tailwinds. We look forward to 2023 with confidence, whilst remaining alert to global supply chain challenges and ongoing inflation pressures.
ENDS
Contacts:
Devro plc
| Chris Dyett | Tel : 07974 974 690 |
| Investor Relations |
FTI Consulting
| Richard Mountain | Tel: 07909 684 466 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFEISMIEESEIF